Transforming GPCR Discovery with AI-Driven Feedback Loops to Deliver Faster, More Reliable & Experimentally Confirmed Therapeutic Candidates
- Accelerating GPCR discovery with an AI-driven feedback loop delivers reliable therapeutic candidates from in silico to clinic within two years
- Naturalizing de novo peptides with AI tools creates natural analogues that retain function and improve developability
- Demonstrating an end-to-end case study shows how this AI workflow advances GPCR therapeutics rapidly to first-in-human trials